Introduction
============

Intracranial aneurysms (IAs), also referred to as cerebral aneurysms, are balloons or sac-like dilatations of arteries inside the brain. To date, IAs remain to be one of the most devastating neurological conditions with a prevalence of 2--3% in the general population ([@b1-etm-0-0-4378]). Unruptured IAs are typically asymptomatic; however, in the event that IAs rupture, this process results in hemorrhage to the subarachnoid space, which is a devastating condition that has been indicated to have a mortality rate of 30--40, and 50% of survivors are left disabled ([@b2-etm-0-0-4378]).

Previous research on the etiology of IAs indicated that the formation of IAs is assumed to be caused by diverse environmental and genetic factors, such as cigarette smoking, excessive alcohol consumption, hypertension, female gender and family history of IAs ([@b3-etm-0-0-4378]--[@b5-etm-0-0-4378]). However, the pathophysiology of IA formation and rupture still remains to be fully elucidated.

Microarray-based gene expression analyses have implied several mechanisms underlying the development of IAs ([@b6-etm-0-0-4378]--[@b10-etm-0-0-4378]). Extracellular matrix turnover factors and inflammatory factors, such as interleukin (IL)-1β, IL-6, IL-8, IL-18, interferon-γ, tumor necrosis factor-α and major histocompatibility complex class II gene, have essential roles in the development, progression, and rupture of aneurysms ([@b11-etm-0-0-4378],[@b12-etm-0-0-4378]). Several pathways, including those associated with inflammatory responses, the immune system, extracellular matrix, and apoptosis are considered to be crucial in the formation, progression, and rupture of IAs ([@b8-etm-0-0-4378],[@b13-etm-0-0-4378]).

MicroRNA (miRNA/miR) are small, non-coding, single-stranded RNA, which are implicated in the post-transcriptional regulation of gene expression of either mRNA degradation or inhibiting translation, followed by protein synthesis repression ([@b14-etm-0-0-4378]). Furthermore, miRNA may modulate pathways and mechanisms of IAs via the control in gene expression. Previous studies have demonstrated that miRNA are involved in vascular remodeling and atherosclerosis ([@b15-etm-0-0-4378],[@b16-etm-0-0-4378]). In addition, a previous study revealed that a subset of inflammation-related miRNA were specifically upregulated in stroke patients with intracerebral hemorrhage and indicated that miR-16, and miR-25 were independent factors for IA occurrence by screening the miRNA expression level of 40 IA patients (20 unruptured and 20 ruptured) and 20 healthy volunteers via microarray assays and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis ([@b17-etm-0-0-4378]).

In the present study, bioinformatic methods were used to merge miRNA and mRNA expression data separately, using data available on the Gene Expression Omnibus database (GEO), to identify differentially expressed mRNA and miRNA between IAs and normal tissues. Subsequently, differentially expressed miRNA target genes were detected by bioinformatics prediction, inversely correlated analysis of miRNA and mRNA expressions were conducted and a miRNA-target gene regulatory network was constructed. The present findings may contribute to future investigations aimed at elucidaing the mechanisms of IAs.

Materials and methods
=====================

### Eligible gene expression profiles

IA expression profiling studies were searched on the GEO database ([ncbi.nlm.gov/geo](ncbi.nlm.gov/geo)), which serves as a public repository for gene expression datasets to meet the growing demand for a public repository for high-throughput gene expression data ([@b18-etm-0-0-4378]). IA expression profiling studies were only retained if they compared miRNA or mRNA expression profiling between IAs and normal tissues.

### Differential analysis of miRNA and mRNA

Raw microarray data from each study was downloaded, and preprocessed with log2 transformation and Z-score normalization. The Linear Models for Microarray Data package in R ([r-project.org](r-project.org)) was used to identify the differently expressed probe sets between IAs and controls using the two-tailed Student\'s t-test and P-values of individual microarray studies were obtained. MetaMA package in R ([r-project.org](r-project.org)) was used to combine P-values from multiple microarray studies and false discovery rate (FDR) was calculated for multiple comparisons using the Benjamini & Hochberg method ([@b19-etm-0-0-4378]). We selected differently expressed mRNA with criterion of FDR \<0.01 and a criterion of FDR \<0.01 for differently expressed miRNA. Heat map analysis was performed using the 'heatmap.2' function of the R/Bioconductor package 'gplots' ([@b20-etm-0-0-4378]).

### Identification of differently expressed miRNA target genes

To understand the potential association between differentially expressed mRNA and miRNA obtained in the present study, the transcriptional targets of the identified miRNA were predicted using the online tools of miRWalk (umm.uni-heidelberg.de/apps/zmf/mirwalk/) ([@b21-etm-0-0-4378]) based on six bioinformatic algorithms (DIANAmT, miRanda, miRDB, miRWalk, PICTAR and TargetScan). Putative targets that were common in the prediction of ≥4 algorithms were selected to match with those identified to be dysregulated in IAs. As miRNA tend to decrease the expression of their target mRNA, differentially expressed target genes whose expression levels were inversely correlated with that of miRNA were to subjected to further investigation ([@b22-etm-0-0-4378]--[@b24-etm-0-0-4378]).

### Functional annotation

Functional enrichment analysis is essential to uncover biological functions of miRNA target genes. To gain insights into the biological functions of miRNA target genes, Gene Ontology (GO) classification and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed using GENECODIS online software (genecodis.cnb.csic.es) ([@b25-etm-0-0-4378]). GO, which includes three categories (biological process, molecular function and cellular component), provides a common descriptive framework of gene annotation and classification for analyzing gene set data. KEGG pathway enrichment analysis was also performed to detect the potential pathway of miRNA target genes based on the KEGG pathway database, which is a recognized and comprehensive database including various types of biochemistry pathways ([@b26-etm-0-0-4378]). FDR \<0.05 was set as the cut-off for selecting significantly enriched functional GO terms and KEGG pathway.

### Construction of the regulatory network of miRNA-target gene in IA

miRNA-target gene interaction networks in IA with miRNA-target gene interacting pairs with expression levels that were inversely correlated were investigated. miRNA regulation networks were visualized using Cytoscape software ([@b27-etm-0-0-4378]).

Results
=======

### Differentially expressed miRNA and mRNA in IA

In the present study, two miRNA and five mRNA expression profiling studies ([@b7-etm-0-0-4378],[@b10-etm-0-0-4378],[@b13-etm-0-0-4378],[@b17-etm-0-0-4378],[@b28-etm-0-0-4378]) of IA were collected ([Table I](#tI-etm-0-0-4378){ref-type="table"}). Following normalization of the original miRNA and mRNA expression datasets, 15 miRNA were regarded as significantly differentially expressed under the threshold of FDR\<0.01. A total of 10 upregulated and five downregulated miRNA were identified ([Table II](#tII-etm-0-0-4378){ref-type="table"}). The upregulated miRNA with the lowest FDR was hsa-miR-188-5p, and the downregulated gene with the lowest FDR was hsa-miR-425. The significantly differentially expressed miRNA were displayed in a heat map ([Fig. 1](#f1-etm-0-0-4378){ref-type="fig"}) and 1,447 genes were identified to be significantly differentially expressed between IAs and controls; 682 genes were upregulated and 765 genes were downregulated.

### Regulatory network of miRNAs and target genes in IA

The miRWalk database was used to predict putative targets of significantly upregulated or downregulated miRNA in IAs. Comparing those putative targets with the list of differentially expressed genes in IAs, miRNA-target gene pairs with inversely correlated expression levels were selected. As a result, 531 miRNA-target gene pairs for the upregulated miRNA, with 29 pairs validated by experiments, and 211 miRNA-target gene pairs for the down regulated miRNA, with nine pairs validated by experiments, were identified ([Table III](#tIII-etm-0-0-4378){ref-type="table"}). The target predictions of hsa-miR-1914 and hsa-miR-425 were not available in miRWalk databases.

Using the 770 miRNA-target gene pairs, a miRNA-target gene regulatory network was constructed. In the miRNA-target gene regulatory network, the top ten miRNA, which included hsa-miR-7, hsa-miR-182, hsa-miR-324-3p, hsa-miR-139-5p, hsa-miR-130b, hsa-let-7f, hsa-miR-18a, hsa-miR-188-5p, hsa-let-7d and hsa-miR-590-5p, were identified to regulate the greatest number of target genes, and the target genes, such as RPS6KA3, TSC1, AIM1, GAS7, GFOD1, GGA2, IGF1, IL28RA and INSR, were regulated by the greatest number of miRNA ([Fig. 2](#f2-etm-0-0-4378){ref-type="fig"}).

### GO classification and KEGG pathways of miRNA target genes

GO classification and KEGG pathway enrichment analysis were performed for miRNA target genes that were differently expressed. Peptide transport (GO, 0015833; FDR, 2.63E-01) and amide transport (GO, 0042886; FDR, 1.31E-01) were indicated to be significantly enriched for biological processes. Molecular functions, ATP binding (GO, 0005524; FDR, 8.93E-02) and adenyl ribonucleotide binding (GO, 0032559; FDR, 6.09E-02) were also significantly enriched. Furthermore, cellular component, collagen trimer (GO, 0005581; FDR, 1.29E-02) and endoplasmic reticulum lumen (GO, 0005788; FDR, 1.30E-01) were significantly enriched ([Table IV](#tIV-etm-0-0-4378){ref-type="table"}). The most significant pathway in the present KEGG analysis was focal adhesion (FDR, 1.07E-08). Pathways in cancer (FDR, 2.49E-08) and cytokine-cytokine receptor interaction (P=5.88E-08) were also indicated to be highly enriched ([Table V](#tV-etm-0-0-4378){ref-type="table"}).

Discussion
==========

IAs are considered to be the most fatal cerebrovascular system disease and are characterized by the apoptosis of smooth muscle cells, degeneration of vessel walls, and activation of the immune system in the aortic wall ([@b29-etm-0-0-4378]). miRNA have been revealed to be critical modulators in vascular biology and disease, such as atherosclerosis, arterial remodeling, angiogenesis, and smooth muscle cell regeneration ([@b30-etm-0-0-4378]). Additionally, miRNA may have vital roles in IA development by regulating downstream genes.

Studies have examined the miRNA and mRNA expression profiles in IA to identify differentially-expressed miRNA and genes. However, inconsistent results were obtained due to platform differences, tissue sampling and control selection in gene expression profiles ([@b9-etm-0-0-4378],[@b31-etm-0-0-4378]--[@b33-etm-0-0-4378]). In the present study, miRNA and mRNA expression data were integrated to identify differentially expressed miRNA and mRNA between IAs and normal tissues. Subsequently, 770 miRNA-target gene pairs with inversely correlated expression levels were identified via bioinformatics prediction were selected to construct a miRNA-target gene regulatory network in IA.

In the miRNA-target gene regulatory network, the top ten miRNA (hsa-miR-7, hsa-miR-182, hsa-miR-324-3p, hsa-miR-139-5p, hsa-miR-130b, hsa-let-7f, hsa-miR-18a, hsa-miR-188-5p, hsa-let-7d and hsa-miR-590-5p) were identified to regulate the greatest number of target genes. Target genes, such as RPS6KA3, TSC1, AIM1, GAS7, GFOD1, GGA2, IGF1, IL28RA and INSR, were indicated to be regulated by the greatest number of miRNA. hsa-let-7d and hsa-let-7f, two members of the let family, which are enriched in endothelium, were revealed to be differently expressed between six intracranial aneurysmal samples and normal superficial temporal arteries by genome-wide microRNA screening ([@b32-etm-0-0-4378]). hsa-miR-7, which is brain-enriched, may be implicated in the pathogenesis of glioblastoma, characterized by microvascular proliferation ([@b34-etm-0-0-4378]--[@b36-etm-0-0-4378]). Furthermore, hsa-miR-7 may function as a tumor suppressor gene to regulate glioblastoma microvascular endothelial cell proliferation by targeting RAF1. To the best of our knowledge, no reports of hsa-miR-7 in IAs have been published. In the present study, 94 targets of hsa-miR-7 were indicated to be significantly enriched in the mTOR signaling pathway and may modulate the apoptosis of muscle cell differentiation in IAs.

RPS6KA3, the target gene regulated by the greatest number of miRNA, has been indicated to be expressed in high levels in regions with high synaptic activity ([@b37-etm-0-0-4378]). Moreover, RPS6KA3 has been suggested to be associated with Coffin-Lowry syndrome, which causes severe mental problems sometimes associated with abnormalities of growth, cardiac abnormalities, kyphoscoliosis, as well as auditory and visual abnormalities ([@b38-etm-0-0-4378]). Molecular evidence from previous studies has revealed that RPS6KA3 may regulate neurotransmitter release by activating phospholipase D production of lipids required for exocytosis and that RPS6KA3 may also function as a proto-oncogene in multiple types of cancer targeted by corresponding miRNA ([@b39-etm-0-0-4378],[@b40-etm-0-0-4378]).

Mutations in either tuberous sclerosis (TSC)1 or TSC2 suppressor genes are able to provoke tuberous sclerosis complex, which is an autosomal dominant disorder promoting the development of benign tumors in multiple organ systems, including the skin, brain, and kidneys, via increasing mammalian target of rapamycin (mTOR) activity ([@b41-etm-0-0-4378],[@b42-etm-0-0-4378]). TSC1 also has a role in arterial remodeling events by affecting the inflammatory and the growth-promoting response of angiotensin II ([@b43-etm-0-0-4378]). Insulin-like growth factor 1 (IGF1) expression has been indicated in the vasculature and lower IGF1 expression levels increased the risk of cardiovascular and abdominal aortic aneurysm in a previous study ([@b44-etm-0-0-4378]). Histological analysis in a swine aneurysm model has demonstrated that IGF1 is upregulated (4-fold) in thrombus organization ([@b45-etm-0-0-4378]).

With regards to the pathways that the identified target genes were involved in, focal adhesion was the most significant pathway revealed in KEGG analysis. This finding was consistent with a previous study by Shi *et al* ([@b8-etm-0-0-4378]), in which Illumina microarray analysis was performed on human the aneurysm wall of IAs. Based on the fact that IAs arise from progressive wall degeneration and remodeling in brain artery walls, focal adhesion may be involved in the pathogenesis of IA.

In conclusion, the present study identified 15 differentially expressed miRNA and 1,447 differentially expressed mRNA between IAs and normal tissues and constructed a regulatory network including 770 miRNA-target gene pairs with inversely correlated expression levels. In this network, several miRNA and genes that may possess key roles in IAs were discovered, such as miRNA hsa-let-7f, hsa-let-7d and hsa-miR-7, and genes, including RPS6KA3, TSC1 and IGF1. The biological pathway of focal adhesion may be involved in the pathogenesis of IA. The findings in the present study may contribute to future investigations aimed at elucidating the mechanisms of IAs.

![Heat-map image representing 15 miRNA that were significantly upregulated or downregulated (false discovery rate \<0.01) in intracranial aneurysms compared with normal controls.](etm-13-06-3239-g00){#f1-etm-0-0-4378}

![Regulatory network between miRNA and target genes in intracranial aneurysms. Diamonds and ellipses represent miRNA and genes, respectively. Red and green colors represent the relatively high and low expression, respectively. miRNA, microRNA.](etm-13-06-3239-g01){#f2-etm-0-0-4378}

###### 

Characteristics of mRNA and miRNA expression profiling of IAs.

  Authors            Year   GEO ID                     Platform                                                                                                   Samples (control:case)   Country   Refs.
  ------------------ ------ -------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------ --------- -----------------------
                            mRNA expression profile                                                                                                                                                  
  Nakaoka et al      2014   GSE54083                   GPL4133Agilent-014850 Whole Human Genome Microarray 4×44K G4112F                                           10:13                    Japan     ([@b28-etm-0-0-4378])
  Jiang et al        2013   GSE46337                   GPL6480Agilent-014850 Whole Human Genome Microarray 4×44K G4112F                                           2: 2                     China     --
  Li et al           2011   GSE26969                   GPL570Affymetrix Human Genome U133 Plus 2.0 Array                                                          3:3                      China     ([@b7-etm-0-0-4378])
  Pera et al         2010   GSE15629                   GPL6244Affymetrix Human Gene 1.0 ST Array                                                                  5:14                     Poland    ([@b10-etm-0-0-4378])
  Weisheimer et al   2007   GSE6551                    GPL570Affymetrix Human Genome U133 Plus 2.0 Array/GPL2507 Sentrix Human-6 Expression BeadChip              5:5                      USA       ([@b13-etm-0-0-4378])
                            miRNA expression profile                                                                                                                                                 
  Li et al           2013   GSE50867                   GPL17725Agilent-031945 human_miRNA_v14 \[miRBase release 16.0 miRNA ID version\]                           4:8                      China     ([@b17-etm-0-0-4378])
  Jiang et al        2013   GSE46336                   GPL16770Agilent-031181 Unrestricted_Human_miRNA_V16.0_Microarray (miRBase release 16.0 miRNA ID version)   3:3                      China     --

miRNA, microRNA; GEO, Gene Expression Omnibus database.

###### 

List of differentially expressed miRNA.

  miRNA                                                          FDR        Fold-change
  -------------------------------------------------------------- ---------- -------------
  Upregulated miRNA                                                         
    hsa-miR-188-5p                                               2.79E-09     2.9750
    hsa-miR-1183                                                 9.74E-08     3.4515
    hsa-miR-18a                                                  6.43E-06     2.6047
    hsa-miR-7                                                    5.18E-05     2.6007
    hsa-miR-590-5p                                               2.85E-04     2.3965
    hsa-let-7d                                                   1.77E-03     2.3005
    hsa-let-7f                                                   2.17E-03     2.3227
    hsa-miR-130b                                                 7.24E-03     2.0646
    hsa-miR-324-3p                                               8.20E-03     1.8100
    hsa-miR-1914^[a](#tfn2-etm-0-0-4378){ref-type="table-fn"}^   8.20E-03     2.4691
  Downregulated miRNA                                                       
    hsa-miR-425^[a](#tfn2-etm-0-0-4378){ref-type="table-fn"}^    1.98E-05   −3.4574
    hsa-miR-182                                                  5.39E-04   −1.3745
    hsa-miR-1825                                                 1.80E-03   −3.1043
    hsa-miR-139-5p                                               2.17E-03   −1.5437
    hsa-miR-193b                                                 9.22E-03   −1.3729

Target predictions were not available via the miRWalk database. miRNA, microRNA; FDR, false discovery rate.

###### 

miRNA-mRNA pairs with inversely correlated expression levels.

  miRNA            Regulation (miRNA)   Target counts   Target mRNA
  ---------------- -------------------- --------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  hsa-miR-188-5p   Up                   59              AEBP2, ATP6V1G1, BAG5, BCL9, BET1, BIN2, CAPN2, CD80, CDC25B, CDON, CLU, CPSF2, CYP1A1, CYYR1, DAAM1, DLC1, FBXO11, FBXO9, FNBP1, FNBP4, FUBP3, GLI2, HMGB1, IL28RA, IL2RA, ING5, KPTN, MX2, MYT1, N6AMT1, PAX8, PCDH9, PER2, PLVAP, PROS1, PSMF1, RPS6KA3, SCN3A, SH3BGRL2, SLC22A3, SPG20, SPOP, SYNJ2BP, SYT11, SYTL2, TACC1, TCL1A, TIAM1, TSN, UPF2, UPF3A, USP14, USP47, UVRAG, ZNF185, ZNF451, ITLN1, GEMIN4, PCNA
  hsa-miR-1183     Up                   9               AEBP2, AIM1, ARG2, CRIM1, DARS, F8, POT1, ROCK2, SLC9A6
  hsa-miR-18a      Up                   63              TP53, GEMIN4, CD8A, ADCY1, AEBP2, AIM1, C1RL, C9orf5, CBX7, CLOCK, CNTN4, CRELD1, CRIM1, CTLA4, DAAM2, DUSP3, EFS, EGLN2, EYA4, FBXO9, FNBP1, GAS7, GFOD1, IGF1, IL28RA, INSR, ITIH5, KIF3B, MC2R, MS4A2, NDUFS1, NEDD4, NPY1R, OSTM1, PCNP, PCSK2, PLEKHG1, POT1, POU6F1, PRMT6, PSMF1, RERG, RPS6KA3, RRAS, SH3BGRL2, SH3BP4, SLC22A3, SLC6A7, SON, SOX8, SRI, STARD7, STAT6, TSC1, TXNIP, UQCRB, USP24, VPS4B, WASF2, ZHX2, ZNF169, ZNF430, ZNF451
  hsa-miR-7        Up                   94              AIM1, ARID2, ATP6V1G1, BAG5, C1GALT1, CAMK1G, CAMK2D, CAPN2, CBX7, CD5, CD8A, CDC14B, CDON, CISH, CLNS1A, COLEC12, CRIM1, CRY2, CXCL12, DCK, DMXL1, EVC, FAM20B, FBLN5, FBXO21, GAS7, GATA4, GATA6, GGA2, GNG4, GRIK3, HN1, IGF1, INHBB, INSR, ITIH5, JAM3, KIF3B, LDB3, LGALS8, LIFR, LUC7L2, MAOA, MC2R, MEIS2, MFAP4, MIPOL1, MRPS36, N6AMT1, NEDD4, NEIL1, PARD6G, PAX8, PIGH, PIK3R3, POLE3, POU6F1, PPP2R2B, PPP2R3A, ProSAPiP1, PSORS1C2, PUM2, RAB5B, RAP1A, RFC5, RIMS3, ROCK2, RPS6KA3, SEMA6A, SLC22A3, SLC9A6, SNAP29, SQSTM1, SS18L1, STEAP2, SYNJ2BP, SYNPR, TCERG1, TCL1A, TGFA, THAP6, TIAM1, TMOD1, TMOD2, TOX, TRDN, TRIM52, TRPV1, TSC1, TSN, UTRN, ZFYVE21, ZNF185, ZNF319
  hsa-miR-590-5p   Up                   49              ANXA1, BBS7, C14orf101, CAMK2D, CAPN2, CNTFR, COL4A4, CRIM1, CTCF, CUBN, DNAJA2, DNM1L, ENPP4, FAT3, FBXO11, FUBP3, FZD6, GFOD1, INSR, IRAK1BP1, ITIH5, KIAA0240, KL, KLF8, LIFR, MAOA, MATN2, MS4A2, OLFM3, PCNA, PELI1, PER2, POT1, PPP1R3D, RABIF, REPS1, RIOK1, RNF38, RPS6KA3, SLMAP, SMARCE1, SRI, TIAM1, TPK1, TRUB1, TSC1, USP24, WSB1, ZNF295
  hsa-let-7d       Up                   55              TAF9, CLU, IGF1, XPO1, TP53, ACTA2, CISH, IFNG, FMR1, ABCB9, ADCY9, AIM1, C14orf28, C1QTNF1, C1RL, CALM1, CD80, CDC14B, CDC25B, CDCA8, COL14A1, COL4A4, CRY2, DPF2, DUSP19, ENPP4, FRAS1, GAS7, GFOD1, GGA2, GNG5, ICOS, IL28RA, INSR, KIAA1609, LDB3, LEPROTL1, LIFR, MC2R, MTHFD2, MUC4, P2RX1, PRDM12, PSORS1C2, ROBO4, RPS6KA3, SCARA3, SPOP, SYT11, TNFSF10, TPK1, TRIM39, TSC1, USP24, UTRN
  hsa-let-7f       Up                   68              ABCB9, ADCY1, ADCY9, AIM1, ATP6V1G1, BMPR1A, C14orf28, C1QTNF1, C1RL, CALM1, CD80, CD8A, CDC14B, CDC25B, CDCA8, CISH, CLU, COL14A1, COL4A4, COL4A5, CRY2, DIABLO, DLC1, DPF2, DUSP19, EGLN2, ENPP4, FMR1, FRAS1, GALR1, GAS7, GFOD1, GGA2, GNG5, ICOS, IFNG, IGF1, IL28RA, IL2RA, INSR, KIAA1609, LDB3, LEPROTL1, MC2R, MEIS2, MTHFD2, MUC4, NTRK3, P2RX1, PAX8, PSORS1C2, RIMS3, RNF38, ROBO4, RPS6KA3, SCARA3, SIPA1L2, SPOP, SYNJ2BP, SYT11, TNFSF10, TP53, TPK1, TSC1, USP24, USP47, UTRN, XPO1
  hsa-miR-130b     Up                   73              ADCY1, ADD2, AIG1, ANK2, BAI3, C1GALT1, CALM2, CAMK2D, CCR6, CDON, CLOCK, CNTN4, COL4A4, CRY1, CXCL12, DEDD2, DNM1L, DOK5, DUSP19, EFS, ENPP4, EPHB4, FAM20B, FAT3, FBXO9, FMR1, FNBP1, FZD6, GGA2, HOXA3, IGF1, IL28RA, INHBB, ITPR1, LDB3, LEPROTL1, METAP1, MLLT10, MRRF, MTMR4, MYT1, NEIL1, PCYOX1, PELI1, PLSCR4, POU6F1, PPIA, PPP1R12A, PTPRG, RAB5B, RNF38, RPS6KA3, RYR2, SCARA3, SCN3A, SLC9A6, SLMAP, SOX21, SPG20, SRPX, STOM, TACC1, TBC1D8, TGFA, THAP6, TSC1, TXNIP, USP47, VPS4B, WDR1, WRN, ZAK, ZNF430
  hsa-miR-130b     Up                   73              ADCY1, ADD2, AIG1, ANK2, BAI3, C1GALT1, CALM2, CAMK2D, CCR6, CDON, CLOCK, CNTN4, COL4A4, CRY1, CXCL12, DEDD2, DNM1L, DOK5, DUSP19, EFS, ENPP4, EPHB4, FAM20B, FAT3, FBXO9, FMR1, FNBP1, FZD6, GGA2, HOXA3, IGF1, IL28RA, INHBB, ITPR1, LDB3, LEPROTL1, METAP1, MLLT10, MRRF, MTMR4, MYT1, NEIL1, PCYOX1, PELI1, PLSCR4, POU6F1, PPIA, PPP1R12A, PTPRG, RAB5B, RNF38, RPS6KA3, RYR2, SCARA3, SCN3A, SLC9A6, SLMAP, SOX21, SPG20, SRPX, STOM, TACC1, TBC1D8, TGFA, THAP6, TSC1, TXNIP, USP47, VPS4B, WDR1, WRN, ZAK, ZNF430
  hsa-miR-324-3p   Up                   83              ADAMTS17, ADCY1, ANKRD11, ARHGAP10, ARHGEF17, BARHL1, BRD2, C1QTNF1, CAMK1G, CBX7, CD34, CD5, CD8A, CDC14B, CDC25B, CLU, COL14A1, COL21A1, CRY2, CXCL12, CYGB, DIABLO, DLC1, DNAJB2, EFS, EGLN2, ELTD1, EPHB4, ESAM, FBXO9, FNBP1, GAS7, GATA4, GFOD1, GGA2, GRIK3, HOXD4, KCND1, KCNS1, KIAA1609, KIF3B, LEPROTL1, LGALS8, LUC7L2, MYLK2, MYT1, NGFR, NTRK3, NUDC, PAX8, PIK3R3, PODN, PPAP2B, PPP1R3D, PRKAR1A, ProSAPiP1, PSMF1, PSORS1C2, RAB5B, RARG, RBM3, RGS3, RGS6, RIMS3, RPL13A, RPS6KA3, SLAMF7, SLC6A7, SOX21, SOX8, SS18, SYT11, TRPV3, TSC1, USP22, USP47, UVRAG, VASP, WASF2, YWHAG, ZNF319, ZNF451, ZNF510
  hsa-miR-182      Down                 84              CDKN1A, MYCN, BAX, EGR1, DOK4, MBNL2, ARF4, PCDH8, XPR1, DDAH1, GALNT2, KITLG, PAPPA, KCNK10, SLC2A3, THBS1, THBS2, ZIC3, GPR68, HOOK3, ADAM9, NAV1, LHFPL2, SIRPB1, VAT1, YKT6, KHDRBS3, MAL2, SLC36A4, COL5A1, SLC31A1, ASB6, CYBB, RDH10, DDX3X, DLAT, FBLN1, C6orf89, MRAS, NLGN4Y, LPHN1, MESDC2, SYNE2, FN1, KIAA0368, NUDT13, D4S234E, KCNH5, HTR2C, KIAA2022, IL16, KIF5C, LRP1, MCL1, MKLN1, OLR1, PC, CECR1, WHSC1L1, PCDHB4, SH3GLB2, THAP10, USP31, PTPRE, NTN4, RNASE6, RNASEL, RRBP1, SCNN1G, SLC11A1, SLC22A5, SRPK1, SSTR2, TBL1X, SLC35A2, TNFSF9, CCND2, NAV2, ACVR1B, SYNGR2, GCM2, KCNK6, KIF23, KIAA0247
  hsa-miR-1825     Down                 6               CDH2, ABCA1, PANX1, SERPINE1, NLK, C2orf3
  hsa-miR-139-5p   Down                 80              MBNL2, DDX3X, ABCA1, FOS, GALNT3, ENAH, TBL1X, PTPRU, DPYSL4, YKT6, ABHD2, BAZ2A, SLC6A14, SLC35A4, MAL2, AP2M1, CCR5, COL11A1, CX3CR1, RDH10, ARX, DSC2, EFNA3, EREG, C6orf89, MRAS, FN1, DDAH1, NR5A1, GALNT2, D4S234E, GLI3, GNAL, USP25, NME7, EHD4, HOXA7, KIAA2022, IGFBP5, HCN1, IL16, JAK3, KCNA3, KIF5C, LHCGR, MARK1, MBNL1, MCL1, KITLG, NF2, PPAT, DIRAS2, BCAS3, PPP2R4, DOK4, PRKCA, CYP4F11, RFXAP, RNASEL, RPL15, SCD, SMOC1, SLC39A8, SGCD, SRPK1, TGFB1, THBS1, TPM3, UFD1L, CUL3, PPFIBP1, KIAA1755, STX11, TNFRSF10D, CCND2, SLC28A2, GCM2, TM9SF4, SPOCK2, TAGLN2
  hsa-miR-193b     Down                 47              SOX9, MCL1, BCL2L10, STMN1, MKLN1, PTPRU, ABHD2, BAZ2A, AP2M1, SLC31A1, CRK, CX3CR1, E2F1, DDAH1, KCNE1L, GALNT2, TNFRSF21, GCLC, APOA2, IGFBP5, MMP14, MYCN, NF2, NUMA1, SERPINE1, RNF141, PPAT, DIRAS2, PPP2R4, PRKCA, KIAA1199, PTPRE, SGCD, SLC20A2, SOX12, TRAF1, ZIC3, AXIN2, HAVCR2, KIAA1755, TNFRSF10B, CCND2, NAV1, SOCS3, ACVRL1, BCAR1, KIAA0195

###### 

Top 15 GO functional annotations of differentially expression miRNA target genes.

  GO ID                GO term                                                                                          Count   P-value    FDR
  -------------------- ------------------------------------------------------------------------------------------------ ------- ---------- ----------
  Biological process                                                                                                                       
    GO:0015833         Peptide transport                                                                                    2   5.21E-05   2.63E-01
    GO:0042886         Amide transport                                                                                      2   5.21E-05   1.31E-01
    GO:0042327         Positive regulation of phosphorylation                                                             19    1.13E-04   1.91E-01
    GO:0044712         Single-organism catabolic process                                                                  15    2.38E-04   3.00E-01
    GO:0010562         Positive regulation of phosphorus metabolic process                                                20    2.38E-04   2.40E-01
    GO:0045937         Positive regulation of phosphate metabolic process                                                 20    2.38E-04   2.00E-01
    GO:0044763         Single-organism cellular process                                                                 320     2.73E-04   1.97E-01
    GO:0060191         Regulation of lipase activity                                                                        5   3.88E-04   2.45E-01
    GO:0030574         Collagen catabolic process                                                                           6   5.20E-04   2.92E-01
    GO:0032963         Collagen metabolic process                                                                           6   5.20E-04   2.62E-01
    GO:0044259         Multicellular organismal macromolecule metabolic process                                             6   5.20E-04   2.39E-01
    GO:0044243         Multicellular organismal catabolic process                                                           6   5.20E-04   2.19E-01
    GO:0044236         Multicellular organismal metabolic process                                                           6   5.20E-04   2.02E-01
    GO:0042325         Regulation of phosphorylation                                                                      20    6.27E-04   2.26E-01
    GO:0032924         Activin receptor signaling pathway                                                                   2   7.48E-04   2.52E-01
  Cellular component                                                                                                                       
    GO:0005581         Collagen trimer                                                                                      8   2.31E-05   1.29E-02
    GO:0005788         Endoplasmic reticulum lumen                                                                          7   4.65E-04   1.30E-01
  Molecular function                                                                                                                       
    GO:0005524         ATP binding                                                                                          7   9.26E-05   8.93E-02
    GO:0032559         Adenyl ribonucleotide binding                                                                        7   1.26E-04   6.09E-02
    GO:0030554         Adenyl nucleotide binding                                                                            7   1.26E-04   4.06E-02
    GO:0043492         ATPase activity, coupled to movement of substances                                                   2   1.47E-04   3.53E-02
    GO:0015399         Primary active transmembrane transporter activity                                                    2   1.47E-04   2.83E-02
    GO:0015405         P-P-bond-hydrolysis-driven transmembrane transporter activity                                        2   1.47E-04   2.36E-02
    GO:0016820         Hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances       2   1.47E-04   2.02E-02
    GO:0042626         ATPase activity, coupled to transmembrane movement of substances                                     2   1.47E-04   1.77E-02
    GO:0048185         Activin binding                                                                                      2   2.69E-04   2.88E-02
    GO:0016361         Activin receptor activity, type I                                                                    2   2.69E-04   2.59E-02
    GO:0017002         Activin-activated receptor activity                                                                  2   2.69E-04   2.36E-02
    GO:0051117         ATPase binding                                                                                       3   3.01E-04   2.42E-02
    GO:0019901         Protein kinase binding                                                                             12    3.39E-04   2.51E-02
    GO:0032549         Ribonucleoside binding                                                                               7   4.08E-04   2.81E-02
    GO:0032550         Purine ribonucleoside binding                                                                        7   4.08E-04   2.62E-02

GO, gene otology; FDR, false discovery rate; ATP, adenosine triphosphate.

###### 

KEGG pathway enrichment analysis of differentially expressed microRNA target genes (Top 15).

  KEGG ID    KEGG term                                Count   FDR        Genes
  ---------- ---------------------------------------- ------- ---------- ----------------------------------------------------------------------------------------------------------------------------------------------------------
  hsa04510   Focal adhesion                           19      1.07E-08   COL4A4, IGF1, PPP1R12A, ROCK2, CCND2, BCAR1, COL4A5, RAP1A, THBS1, MYLK2, PRKCA, CRK, PIK3R3, CAPN2, THBS2, VASP, COL5A1, COL11A1, FN1
  hsa05200   Pathways in cancer                       23      2.49E-08   COL4A4, AXIN2, KITLG, FOS, FZD6, TGFA, IGF1, GLI3, COL4A5, E2F1, TPM3, PRKCA, CRK, PIK3R3, CDKN1A, TGFB1, BAX, GLI2, TP53, PAX8, TRAF1, FN1, EGLN2
  hsa04060   Cytokine-cytokine receptor interaction   20      5.88E-08   INHBB, TNFRSF10D, KITLG, BMPR1A, TNFRSF10B, CNTFR, IL28RA, TNFRSF21, CX3CR1, IFNG, LIFR, TGFB1, IL2RA, NGFR, CCR5, ACVR1B, CXCL12, TNFSF9, TNFSF10, CCR6
  hsa05146   Amoebiasis                               13      1.03E-07   ARG2, COL4A4, GNAL, ADCY1, COL4A5, RAB5B, IFNG, PRKCA, PIK3R3, TGFB1, COL5A1, COL11A1, FN1
  hsa04062   Chemokine signaling pathway              15      2.66E-06   TIAM1, ADCY1, ROCK2, BCAR1, ADCY9, CX3CR1, RAP1A, CRK, PIK3R3, JAK3, GNG5, CCR5, CXCL12, GNG4, CCR6
  hsa05214   Glioma                                     8     8.41E-05   CAMK2D, TGFA, IGF1, E2F1, PRKCA, PIK3R3, CDKN1A, TP53
  hsa05144   Malaria                                    4     1.01E-04   IFNG, THBS1, TGFB1, THBS2
  hsa04350   TGF-beta signaling pathway                 4     1.01E-04   IFNG, THBS1, TGFB1, THBS2
  hsa04670   Leukocyte transendothelial migration     10      1.06E-04   JAM3, ROCK2, BCAR1, ESAM, RAP1A, PRKCA, PIK3R3, CYBB, VASP, CXCL12
  hsa04115   p53 signaling pathway                      8     1.18E-04   TNFRSF10B, IGF1, CCND2, THBS1, SERPINE1, CDKN1A, BAX, TP53
  hsa04971   Gastric acid secretion                     8     1.36E-04   KCNK10, CAMK2D, ADCY1, ADCY9, MYLK2, PRKCA, ITPR1, SSTR2
  hsa04310   Wnt signaling pathway                    11      1.42E-04   NLK, CAMK2D, AXIN2, FZD6, ROCK2, CCND2, PRKCA, DAAM2, TBL1X, TP53, DAAM1
  hsa04722   Neurotrophin signaling pathway           10      1.56E-04   CAMK2D, RAP1A, CRK, PIK3R3, YWHAG, NGFR, BAX, RPS6KA3, TP53, NTRK3
  hsa04630   Jak-STAT signaling pathway               11      1.58E-04   CNTFR, CCND2, I L28RA, IFNG, LIFR, STAT6, SOCS3, PIK3R3, JAK3, IL2RA, CISH
  hsa04020   Calcium signaling pathway                  6     1.61E-04   CAMK2D, ADCY1, ADCY9, MYLK2, PRKCA, ITPR1

KEGG, Kyoto Encyclopedia of Genes and Genomes; FDR, false discovery rate; TGF, transforming growth factor; STAT, signal transducer and activator of transcription.
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